• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

À̼öÇö

  • Áø·á°ú

    Á¾¾çÇ÷¾×³»°ú

  • Àü¹®Áø·áºÐ¾ß

    ´ëÀå¾Ï, ¼ÒÈ­±â¾Ï, À¯Àü¼º¾Ï À¯Àü»ó´ã

  • ´ã´çŬ¸®´Ð

  • °ü·Ã¼¾ÅÍ

    ¾Ïº´¿ø ȨÆäÀÌÁö

À̼öÇö

À̼öÇö ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
Á¾¾çÇ÷¾×³»°ú
¿ÀÈÄ
-
¿ÀÈÄ
¿ÀÀü
¿ÀÀü
- ´ëÀå¾Ï , ¼ÒÈ­±â¾Ï , À¯Àü¼º¾Ï À¯Àü»ó´ã
¾Ïº´¿ø
Á¾ÀÏ
-
¿ÀÀü
¿ÀÀü
¿ÀÀü
- ´ëÀå¾Ï , ¼ÒÈ­±â¾Ï , À¯Àü¼º¾Ï À¯Àü»ó´ã

À̼öÇö ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 2010 .03  ~  2012 .08  :  ¼º±Õ°ü´ëÇб³ ´ëÇпø ÀÇÇйڻç Á¹¾÷
  • 2000 .03  ~  2004 .02  :  ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
  • 1998 .03  ~  2000 .02  :  ¼­¿ï´ëÇб³ »çȸÇаú ´ëÇпø ¹Ú»ç¼ö·á
  • 1995 .03  ~  1997 .02  :  ¼­¿ï´ëÇб³ »çȸÇаú ´ëÇпø ¼®»çÁ¹¾÷

°æ·Â

more
  • 2019 .03  ~   :  °í´ë¾È¾Ïº´¿ø Á¾¾çÇ÷¾×³»°ú
  • 2014 .03  ~  2019 .02  :  Á¦¾àȸ»çÀÇ»ç (Pfizer and Celgene)
  • 2011 .03  ~  2014 .02  :  ½ÅÃ̼¼ºê¶õ½ºº´¿ø Á¾¾ç³»°ú ÀÓ»óÁ¶±³¼ö
  • 2010 .03  ~  2011 .02  :  ½ÅÃ̼¼ºê¶õ½ºº´¿ø Á¾¾ç³»°ú Àӻ󿬱¸Á¶±³¼ö
  • 2009 .03  ~  2010 .02  :  »ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú ÀüÀÓÀÇ
  • 2004 .03  ~  2009 .02  :  ½ÅÃ̼¼ºê¶õ½ºº´¿ø ÀÎÅÏ, ³»°ú Àü°øÀÇ

ÇÐȸȰµ¿

more
  •  ~   :  ¹Ì±¹ÀÓ»óÁ¾¾çÇÐȸ ȸ¿ø
  •  ~   :  ¹Ì±¹ ¾Ï ¿¬±¸ÇÐȸ ȸ¿ø
  •  ~   :  À¯·´Á¾¾ç³»°úÇÐȸ ȸ¿ø
  •  ~   :  ´ëÇѾÏÇÐȸ ȸ¿ø
  •  ~   :  ´ëÇÑÇ׾Ͽä¹ý ¿¬±¸È¸ ±¹Á¦Çù·ÂÀ§¿ø, IRB À§¿ø, QA À§¿ø
  •  ~   :  ´ëÇÑÁ¾¾ç³»°úÇÐȸ ¹«ÀÓ¼Ò ÀÌ»ç

±¹³»È°µ¿

more
  •  ~   :  (»ç) Çѱ¹ÀÌÁֹΰǰ­Çùȸ ÀÇ·á½É»çÀ§¿ø

³í¹®

more
  • [SCI] (Patient-reported outcomes of palbociclib plus exemestane with GnRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer from the YoungPearl phase ll trial (KCSG-BR 15-10))
  • [SCI] (Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea)
  • [SCI] (Comparison of tolerability between sunitinib ¡®2-week on, 1-week off¡¯ schedule versus standard ¡®4-week on, 2-week off¡¯ schedule: a systematic review and meta-analysis)
  • [SCI] (Clinical application of targeted deep sequencing in metastatic colorectal cancer patients: actionable genomic alteration in K-MASTER project)
  • [SCI] (Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea)
  • [SCI] (Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures)
  • [SCI] (Effects of a Mindfulness-Based Stress Reduction Program on the Physical and Psychological Status and Quality of Life in Patients With Metastatic Breast Cancer)
  • [SCI] (A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy)
  • [SCI] (Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results)
  • [SCI] (Statins affect ETS-1-overexpressing triple-negative breast cancer cells by restroring DUSP4 deficiency)
  • [SCI] (Prognostic Value of Axillary Nodal Ratio After Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide (AC) Followed by Docetaxel (DOC): A Multicenter Retrospective Cohort Study)
  • [SCI] (Characteristics of venous thromboembolism in pancreatic adenocarcinoma in East asian ethnics: a large population-based observational study)
  • [SCI] (Quality of life in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine chemotherapy: results from phase lll, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02))
  • [SCI] (Prediction of short- and long-term survival for advanced cancer patients after ICU admission)
  • [SCI] (Trends in receiving chemotherapy for advanced cancer patients at the end of life)
  • [SCI] (Pain palliation in patients with bone metastases using magnetic resonance-guided focused ultrasound with confirmal bone system: a preliminary report)
  • [SCI] (Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevelance, clinicopathological features and prognostic implication)
  • [SCI] (Effective treatment of solitary pituitary metastasis with panhypopituitarism in HER2-positive breast cancer by lapatinib)
  • [SCI] (Phase ll study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG) GY 10-10)
  • [SCI] (Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma)
  • [SCI] (Case series of different onset of skin metastasis according to the breast cancer subtype)
  • [SCI] (Overexpression of catalase, ROS scavenge enzyme, is related with good prognosis in TNBC)
  • [SCI] (Craniofacial osteosarcoma : single institutional experience in Korea)
  • [SCI] (Radiation recall dermatitis induced by Trastuzumab)
  • [SCI] (Psychosocial impact of cancer patients on their family members)
  • [SCI] (S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial)
  • [SCI] (Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer)
  • [SCI] (FOXP3 expression in related to high grade Ki-67 index and poor prognosis in lymph node-positive breast cancer patients)
  • [SCI] (Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors)
  • [SCI] (Prognostic impact of FOXP3 expression in triple-negative breast cancer)
  • [SCI] (Phase lll, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after chieving disease control with six cycles of gemcitab 1. plus paclitaxel as first-line chemotherapy: KCSG-BR07-02)
  • [SCI] (Muticentre phase ll trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905))
  • [SCI] (Application of the adjuvant! Online model to Korean breast cancer patients: an assessment of prognostic accuracy and development of an alternative prognostic tool)
  • [SCI] (Statins and the risk of gastric cancer in diabetes patients)
  • [SCI] (Successful Sirolimus treatment of multiple visceral Kaposi¡¯s sarcoma in a renal allograft patient)
  • [SCI] (Prediction of outcomes of for patients with brain parenchymal metastases from breast (BC): a new BC-specific prognostic model and a nomogram)
  • [SCI] (Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma)
  • [SCI] (Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study)
  • [SCI] (Overexpression of calss lll beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy)
  • [SCI] (Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations)

Àú¼­

more
  • ÇÑÂʰ¡½¿À¸·Î »ç¶ûÇϱâ
  • ±Â¹ÙÀÌ À¯¹æ¾Ï

ÃÖÁ¾¼öÁ¤ÀÏ : 2020.11.03